Sakurai E, Sakurai E, Maeyama K, Watanabe T, Jossan S S, Oreland L
Department of Pharmaceutics I, Tohoku College of Pharmacy, Sendai, Japan.
Methods Find Exp Clin Pharmacol. 1995 Nov;17 Suppl C:46-50.
The effects of an H3 agonist, (R)-alpha-methylhistamine (alpha-MeHA), and an H3 antagonist, thioperamide, on monoamine oxidase (MAO) activity in rat hypothalamus were studied in vitro. Thioperamide was more potent in inhibiting MAO-B than MAO-A activity; MAO-B activity in rat hypothalamic homogenates was competitively inhibited by thioperamide with a Ki value of 175 micronM. From this in vitro experiment, the conversion of N-telemethylhistamine to N-tele-methylimidazoleacetic acid may be inhibited by thioperamide, suggesting that thioperamide may affect the regulation of histamine metabolism within histaminergic neurons. In contrast with the results obtained with thioperamide, alpha-MeHA inhibited MAO-A more potently than MAO-B activity; the Ki values for MAO-A and -B of hypothalamic homogenates were estimated to be 1.1 and 3.3 mM, respectively. The weak inhibitory effect of alpha-MeHA for MAO-B does not seem to be a major cause of changes in N-tele-methylhistamine concentrations.
在体外研究了H3激动剂(R)-α-甲基组胺(α-MeHA)和H3拮抗剂硫代哌啶对大鼠下丘脑单胺氧化酶(MAO)活性的影响。硫代哌啶对MAO-B的抑制作用比对MAO-A的活性更强;硫代哌啶对大鼠下丘脑匀浆中MAO-B活性有竞争性抑制作用,Ki值为175μM。从该体外实验可知,硫代哌啶可能抑制N-tele甲基组胺向N-tele甲基咪唑乙酸的转化,这表明硫代哌啶可能影响组胺能神经元内组胺代谢的调节。与硫代哌啶的结果相反,α-MeHA对MAO-A的抑制作用比对MAO-B的活性更强;下丘脑匀浆中MAO-A和-B的Ki值分别估计为1.1和3.3 mM。α-MeHA对MAO-B的微弱抑制作用似乎不是N-tele甲基组胺浓度变化的主要原因。